Press Releases Nkarta, Inc.

Equities

NKTX

US65487U1088

Market Closed - Nasdaq Other stock markets 01:30:00 10/05/2024 am IST			5-day change	1st Jan Change
6.3 ^USD	-1.56%		-16.33%	-4.55%

09/05	Nkarta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
26/03	Canaccord Genuity Adjusts Nkarta's Price Target to $16 From $15, Keeps Buy Rating	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights	10/05	AQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors	08/04	BU
Law Offices of Howard G. Smith Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors	06/04	BU
The Law Offices of Frank R. Cruz Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors	06/04	BU
Nkarta to Participate in Upcoming Investor Conferences	04/04	AQ
Nkarta Announces Pricing of $240 Million Underwritten Offering	25/03	AQ
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights	22/03	AQ
Nkarta to Participate in Upcoming Investor Conferences	28/02	AQ
Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition	10/12	AQ
Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights	10/11	AQ
Nkarta to Participate at Upcoming Investor Conferences	07/11	AQ
Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer Cell Therapy in Lupus Nephritis	18/23/18	AQ
Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis	17/23/17	AQ
Nkarta to Host Conference Call on Tuesday, October 17 at 8am ET to Discuss Expansion of Clinical Pipeline and Organizational Cost Measures	17/23/17	AQ
Rezo Therapeutics Appoints Nadir Mahmood, Ph.D., as Chief Executive Officer	21/23/21	AQ
Nkarta Reports Second Quarter 2023 Financial Results and Corporate Highlights	10/23/10	AQ
Nkarta to Participate at Upcoming Investor Conference	03/23/03	AQ
Nkarta Appoints Alyssa Levin Chief Financial and Business Officer	06/23/06	AQ
Nkarta : NKX101 Clinical Update Presentation – June 2023	27/23/27	PU
Nkarta Updates Clinical Progress of CAR-NK Cell Therapy NKX101 for Patients with Relapsed or Refractory Acute Myeloid Leukemia	27/23/27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Nkarta, Inc.

Equities

NKTX

US65487U1088

Press Releases

Filters